Cancer chemotherapeutics - angiogenesis agents: October 1999 - March 2000
Author:
- Richard D ConnellRCRichard D Connell
- 1 June 2000
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 10 (6) , 767-786
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tumor angiogenesis: past, present and the near futureCarcinogenesis, 2000
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000
- New Roles for Src Kinases in Control of Cell Survival and AngiogenesisCell, 2000
- Fibroblast growth factor-2The International Journal of Biochemistry & Cell Biology, 2000
- Is angiogenesis inhibition the Holy Grail of cancer therapy?Current Opinion in Oncology, 2000
- The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseEuropean Journal of Cancer, 2000
- Protein Tyrosine Kinase Inhibitors as Novel Therapeutic AgentsPharmacology & Therapeutics, 1999
- Tyrosine kinase inhibitors in cancer treatment (Part II)Expert Opinion on Therapeutic Patents, 1998
- Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysisThe Journal of Pathology, 1995
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971